Gene: ZNF785
Official Full Name: zinc finger protein 785provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23989 | ZNF785 Knockout cell line (HeLa) | Human | ZNF785 | 1:3~1:6 | Negative | Online Inquiry |
KO23990 | ZNF785 Knockout cell line (HEK293) | Human | ZNF785 | 1:3~1:6 | Negative | Online Inquiry |
ZNF785 Gene Knockout Cell Lines represent a significant advancement in the field of genetic research, specifically designed for the study of the ZNF785 gene, which has been implicated in various cellular processes, including transcriptional regulation and developmental pathways. This product enables researchers to create precise cellular models devoid of the ZNF785 gene, facilitating the investigation of its role in gene expression, cellular behaviors, and potential links to diseases.
These knockout cell lines operate via CRISPR-Cas9 genome editing technology, providing high efficiency and specificity in gene disruption. By inducing targeted breaks in the DNA sequence of the ZNF785 gene, the cell lines allow for study of phenotypic changes relative to parental cell lines. This mechanism opens avenues for scientists to explore the downstream effects associated with the absence of ZNF785, offering insights into its functional role in health and disease.
The scientific importance of ZNF785 knockouts lies in their application in understanding complex genetic interactions and pathways, making them invaluable tools in both basic research and clinical settings. They can aid in deciphering the mechanisms of diseases, particularly those linked to aberrant gene expression and regulatory functions, potentially leading to novel therapeutic strategies.
Compared to traditional gene knockdown methods, our ZNF785 Gene Knockout Cell Lines offer permanent and heritable modifications, eliminating the variability often observed with transient knockdown approaches. This quality ensures more reliable and reproducible experimental outcomes, which is critical for high-stakes research.
Researchers and clinicians benefit immensely from utilizing these cell lines, as they underscore our commitment to advancing scientific knowledge and therapeutic development. By leveraging our expertise in cellular biology and gene editing technologies, we provide high-quality biological products that empower the scientific community to make significant strides in their work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.